ropeg in polycythemia vera: long-term proud-pv and conti-pv results
Published 4 years ago • 979 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
3:15
updates on ropeginterferon in pv
-
1:54
ongoing trials in polycythemia vera: low-pv & verify
-
2:02
conti-pv: a 2-year follow-up of interferon product aop2014
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
6:01
common signs and symptoms of polycythemia vera
-
4:32
living with polycythemia vera
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
2:16
ropeginterferon vs standard therapy for polycythemia vera
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:12
contemporary challenges in polycythemia vera management
-
3:10
the stories behind the advances in polycythemia vera
-
2:06
clinical updates on the use of ropeginterferon for polycythemia vera
-
3:07
the current treatment algorithm for polycythemia vera
-
5:40
lba: results of revive - rusfertide in patients with polycythemia vera
-
2:54
an update on the use of idasanutlin in polycythemia vera
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
10:20
new guidelines for the treatment and management of polycythemia vera
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
2:08
phase iii trial of rusfertide in patients with polycythemia vera
-
3:19
targeting jak2 v617f vaf in polycythemia vera & the efficacy of ropeginterferon alfa-2b